The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 359:1060-1062 September 4, 2008 Number 10
NextNext

Predicting Mortality in Cirrhosis — Serum Sodium Helps
Andrés Cárdenas, M.D., and Pere Ginès, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Kim, W. R.
-PubMed Citation
Liver transplantation is widely accepted as a standard method of treatment for many patients with advanced cirrhosis, and survival rates among patients who have undergone liver transplantation approach 80% at 3 years.1 These success rates, together with a high prevalence of chronic liver diseases and a shortage of donors, have led to a steady increase in the number of patients awaiting liver transplantation. More than 16,000 patients in the United States are on the waiting list, and approximately 6000 liver transplantations are performed each year.2 With this striking imbalance, the rate of death among patients on the waiting list has . . . [Full Text of this Article]


Source Information

From the Institut Clinic de Malalties Digestives i Metaboliques, Hospital Clinic, University of Barcelona, Barcelona.




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.